XML 58 R40.htm IDEA: XBRL DOCUMENT v3.24.3
Financial Instruments and Fair Value Measurements (Tables)
12 Months Ended
Sep. 30, 2024
Fair Value Disclosures [Abstract]  
Schedule of Cash and Cash Equivalents
The following reconciles cash and equivalents and restricted cash reported within the Company's consolidated balance sheets at September 30, 2024 and 2023 to the total of these amounts shown on the Company's consolidated statements of cash flows:
(Millions of dollars)20242023
Cash and equivalents$1,717 $1,416 
Restricted cash139 65 
Cash and equivalents and restricted cash$1,856 $1,481 
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The fair values of the Company’s financial instruments are as follows:
(Millions of dollars)Basis of fair value measurement (See Note 1)20242023
Institutional money market accounts (a)Level 1$285 $373 
Current portion of long-term debt (b)Level 21,748 1,122 
Long-term debt (b)Level 217,199 12,850 
(a)These financial instruments are recorded within Cash and equivalents on the consolidated balance sheets. The institutional money market accounts permit daily redemption.
(b)Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments.
Transfer of Financial Assets Accounted for as Sales The amounts transferred and yet to be remitted under factoring arrangements are provided below.
(Millions of dollars)202420232022
Trade receivables transferred to third parties under factoring arrangements$1,385 $2,615 $1,215 
(Millions of dollars)20242023
Amounts yet to be collected and remitted to the third parties254 357